It has been clinically documented that proteoglycan levels decline within the hair follicle in age-related or genetic hair loss (Androgenetic Alopecia), post-pregnancy hair loss (Postpartum Effluvium) and whilst experiencing stress-related hair loss (Telogen Effluvium).
The hair follicle relies on a fine-tuned dialogue between different compartments in the skin and around the hair follicle, regulated by a delicate balance between various important growth influencers. Proteoglycans’ roles in hair growth control should always be considered when addressing hair growth disorders, no matter their cause or type, as proteoglycans can effectively modulate the growth factors.
The Hair Growth Cycle consists of three phases: the Anagen (growth) phase, the Catagen (transition) phase and the Telogen (resting) phase. The hair follicle returns to begin a new Anagen phase after the hair has been shed in the Telogen phase, thereby completing the cycle, normalising the hair growth and improving the overall hair quality.
Several factors can influence the healthy Hair Growth Cycle and disrupt normal hair growth resulting in a negative cycle of increased shedding and weak or no re-growth at all. By utilising a Proteoglycan Replacement Therapy, which is rich in specific bioactive proteoglycans, the hair follicles can be induced back into the Anagen phase and begin a new, revitalised Hair Growth Cycle, leading to increased hair growth and hair quality.
There is a well-founded scientific basis for recommending Proteoglycan Replacement Therapy as a primary therapy for subjects suffering from hair loss or hair growth disorders in general.
Hair Growth+ inCLINIC with Marilex®-P is a bioactive proteoglycan formula used as a Proteoglycan Replacement Therapy and is specifically designed to normalise the Hair Growth Cycle and promote normal, healthy hair growth.
Hair loss and hair growth disruptions can be explained by a ‘lower than normal’ concentration of hair growth regulating proteoglycans that causes follicular degradation – this is known as Proteoglycan Follicular Atrophy.
Proteoglycan Follicular Atrophy is today a clinically established pathology and is a condition where a wasting away of selective proteoglycans from the dermal papilla, the inner and outer root sheath, occurs, coupled with an ever-decreasing ability of the body to reproduce these in a normal, healthy manner.
Hair Growth+ inCLINIC, with the unique, proprietary Marilex®-P, is a scientifically developed Proteoglycan Replacement Therapy formulated to support normal healthy hair growth by addressing Proteoglycan Follicular Atrophy, which is an underlying cause of almost all cases of hair growth disruptions, no matter the cause or type.
There are many causes for hair loss, e.g., stress, genetics, hormones, childbirth, medicine, health, diabetes, diet, smoking and hairstyling. No matter the cause, the normal, healthy Hair Growth Cycle is always negatively affected.
The Hair Growth Cycle is the all-important mechanism regulating hair growth on the scalp. In order to restore hair and treat hair loss, it is, therefore, necessary to normalise and support the Hair Growth Cycle.
One available and safe method of increasing the concentration of specific hair follicle proteoglycans and normalising the Hair Growth Cycle is to orally administer the specific bioavailable proteoglycans, referred to as Proteoglycan Replacement Therapy.
There is a well-founded scientific and clinical basis for using Proteoglycan Replacement Therapy as primary therapy for subjects suffering hair loss or hair growth disorders, no matter the cause or type. It has been documented that proteoglycan levels decline within the hair follicle in age-related or genetic hair loss (Androgenetic Alopecia), post-pregnancy hair loss (Postpartum Effluvium) and whilst experiencing stress-related hair loss (Telogen Effluvium).
Hair Growth+ inCLINIC, with Marilex®-P is a bioactive proteoglycan formula used as a Proteoglycan Replacement Therapy and is specifically designed to normalise the Hair Growth Cycle and promote normal, healthy hair growth.
8 out of 10 users saw a significant improvement after taking Hair Growth+ inCLINIC – YES, IT WORKS!
Marilex®-P sets Hair Growth+ inCLINIC by Nourkrin® apart from any other products claiming to contain similar ingredients, as Marilex®-P is a proprietary ingredient protected by exclusive intellectual property rights for more than 30 years.
Marilex®-P is rich in specific follicular bioactive proteoglycans obtained through a proprietary enzymatic fractionation of a specific fish extract and contains high proportions of specific bioactive papillary proteoglycans that are critical to normal healthy female hair follicle growth and cycling during Telogen Effluvium (hair shedding after giving birth) and Female Pattern Hair Loss in general (Genetic Hair Loss).
Marilex®-P restores the key proteoglycans in and around the hair follicles that are experiencing Proteoglycan Follicular Atrophy, which is clinically documented to be a major underlying cause of hair loss in females and males alike, thereby inducing and prolonging the Anagen (growth) phase and ultimately leading to a normalisation of the healthy Hair Growth Cycle.
Marilex®-P (fractionated fish extract with specific lectican proteoglycans) is made with the highest quality, natural raw materials using an exclusive, protected, enzymatic extraction technology and is accepted by health authorities on all continents of the globe including the FDA, Anvisa, Cofepris and European Food Safety Authority etc.
Each Hair Growth+ inCLINIC tablet contains the precise amount of Marilex®-P that has been used in the clinical studies documenting the efficacy. The other ingredients further influence the Hair Growth Cycle, which is why the bioactive proteoglycan formula of Hair Growth+ inCLINIC is not just a simple multivitamin, but an effective, scientifically tested and tried Proteoglycan Replacement Therapy for hair growth disruptions in women and men experiencing Proteoglycan Follicular Atrophy.
There have been no known side effects in the more than 30 years that Nourkrin® has been available.
The safety and side effect free tolerability of Hair Growth+ inCLINIC with Marilex®-P have been demonstrated in multiple clinical trials featured in leading international medical journals. Hair Growth+ inCLINIC, with Proteoglycans by Nourkrin®, is completely safe and 100% drug-free. It’s entirely based on drug-free ingredients, which are evaluated as safe by food and drug authorities globally. Furthermore, health authorities on all continents accept Marilex®-P, including the FDA, Anvisa, Cofepris and EFSA (European Food Safety Authority).
Each Hair Growth+ inCLINIC tablet contains the exact quantities of Marilex®-P proven effective in the respective clinical studies. Additional ingredients further influence the Hair Growth Cycle, and Hair Growth+ inCLINIC is, therefore, not simply a multivitamin but an effective, scientifically proven hair growth product.